Research Priorities in Hypertrophic Cardiomyopathy: Report of a Working Group of the National Heart, Lung, and Blood Institute
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
ypertrophic cardiomyopathy (HCM) is a myocardial dis- order characterized by left ventricular (LV) hypertrophy without dilatation and without apparent cause (ie, it occurs in the absence of severe hypertension, aortic stenosis, or other cardiac or systemic diseases that might cause LV hypertrophy).Numerous excellent reviews and consensus documents provide a wealth of additional background.[1][2][3][4][5][6][7][8] HCM is the leading cause of sudden death in young people and leads to significant disability in survivors.It is caused by mutations in genes that encode components of the sarcomere.Cardiomyocyte and cardiac hypertrophy, myocyte disarray, interstitial and replacement fibrosis, and dysplastic intramyocardial arterioles characterize the pathology of HCM.Clinical manifestations include impaired diastolic function, heart failure, tachyarrhythmia (both atrial and ventricular), and sudden death.At present, there is a lack of understanding of how the mutations in genes encoding sarcomere proteins lead to the phenotypes described above.Current therapeutic approaches have focused on the prevention of sudden death, with implantable cardioverter defibrillator placement in high-risk patients.But medical therapies have largely focused on alleviating symptoms of the disease, not on altering its natural history.The present Working Group of the National Heart, Lung, and Blood Institute brought together clinical, translational, and basic scientists with the overarching goal of identifying novel strategies to prevent the phenotypic expression of disease.Herein, we identify research initiatives that we hope will lead to novel therapeutic approaches for patients with HCM. EpidemiologyThe epidemiology of HCM suggests that it is present in Ϸ1 in 500 adults.9 Because of the delay in phenotypic expression of the disease, HCM is not commonly recognized clinically in young children, but when it is, it is much more frequently recognized in males.10 This is likely due to greater penetrance in young males.11,12 HCM is underdiagnosed clinically in blacks and in women, yet women tend to present with more marked heart failure than men when they are diagnosed later in life.13,14 There is no overall difference in mortality, including sudden cardiac death, between men and women, although sudden cardiac death on the athletic field predominantly occurs in men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224 · cited 3×
“4 for their family members.(12) That said, much of the data provided by these studies has one or more limitations including relatively small sample sizes, center-specific differences in diagnostic criteria for HCM, and differences in practice patterns and patient follow-up.”
Self-citation
Cited by
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Self-citationAckerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., Camm, A. J., Ellinor, P. T., Gollob, M., Hamilton, R., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.05.020 · Cited by 1,479
Self-citation2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Self-citationAckerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., Camm, A. J., Ellinor, P. T., Gollob, M., Hamilton, R., et al. (2011) · Europace · doi:10.1093/europace/eur245 · Cited by 895
Self-citationForce, T., & Kolaja, K. L. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3252 · Cited by 363
Self-citationOlivotto, I., Cecchi, F., Poggesi, C., & Yacoub, M. H. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.967026 · Cited by 352
Dass, S., Suttie, J. J., Piechnik, S. K., Ferreira, V. M., Holloway, C. J., Banerjee, R., Mahmod, M., Cochlin, L., Karamitsos, T. D., Robson, M. D., et al. (2012) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.976738 · Cited by 348
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.020 · Cited by 322
Self-citationCardim, N., Galderisi, M., Edvardsen, T., Plein, S., Popescu, B. A., D'Andrea, A., Bruder, O., Cosyns, B., Davin, L., Donal, E., et al. (2015) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jeu291 · Cited by 284
Identifying Sarcomere Gene Mutations in Hypertrophic Cardiomyopathy: A Personal History
Seidman, C. E., & Seidman, J. G. (2011) · Circulation Research · doi:10.1161/circresaha.110.223834 · Cited by 271
Self-citationMaron, B. J., Rowin, E. J., Casey, S. A., & Maron, M. S. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2015.0354 · Cited by 246
Self-citationMechanisms of disease: hypertrophic cardiomyopathy
Frey, N., Luedde, M., & Katus, H. A. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.159 · Cited by 235
Telomere shortening is a hallmark of genetic cardiomyopathies
Chang, A. C. Y., Chang, A. C. H., Kirillova, A., Sasagawa, K., Su, W., Weber, G., Lin, J., Termglinchan, V., Karakikes, I., Seeger, T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714538115 · Cited by 91
Self-citation
Metadata
- Authors
- Force, T., Bonow, R. O., Houser, S. R., Solaro, R. J., Hershberger, R. E., Adhikari, B., Anderson, M. E., Boineau, R., Byrne, B. J., Cappola, T. P., Kalluri, R., LeWinter, M. M., Maron, M. S., Molkentin, J. D., Ommen, S. R., Regnier, M., Tang, W. H. W., Tian, R., Konstam, M. A., Maron, B. J., & Seidman, C. E.
- Venue
- Circulation
- Published
- 2010-09-14
- Volume
- 122
- Issue
- 11
- Pages
- 1130-1133
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2142387793
- Cited by
- 120
- References
- 2
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.